HomePodcastsThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug CompanyThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug CompanyNovember 20, 2025 · 1 h 13 minPlay episodeShare from this pointShow notesNeil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.All episodes of The Long Run with Luke Timmerman